)
)
)
Vincere Biosciences Inc
Vincere Biosciences is a Boston-based, AI-powered biotechnology company developing first-in-class therapeutics that target the fundamental mechanisms of aging and disease. By enhancing mitophagy—the cell’s natural system for clearing damaged mitochondria—Vincere aims to stop the progression of Parkinson’s disease and other age-related conditions at their root. Powered by a proprietary virtual cell platform and rigorous, mechanism-driven science, Vincere is building a patent-protected pipeline of transformative medicines designed not just to treat symptoms, but to meaningfully improve and extend human life
What is your next catalyst (value inflection) update?
IND
Year Founded
2018
Lead Product in Development
Selective USP30 inhibitor (oral) being advanced as the development candidate for Parkinson’s disease
Development Phase of Lead Product
Pre-Clinical
Number of Unlicensed Products Looking for Licensing
2
CEO/Top Company Official
Bahareh (Spring) Behrouz
When you expect your next catalyst update?
July 2026
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
